PIK3CA and colorectal carcinoma: Previous studies have showed how, in KRAS-mutant CRC, PI3K activation is mediated by RTK signaling, despite KRAS being capable of cross-activating PI3K [20, 28, 29], for this reason we investigated the status of multiple receptors.